Catalyst Pharmaceuticals, Inc.
CPRX
$19.96
-$0.66-3.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 52.11M | 56.74M | 55.94M | 43.88M | 40.79M |
| Total Depreciation and Amortization | 9.46M | 9.46M | 9.46M | 9.45M | 9.44M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.78M | 897.00K | 1.04M | -6.93M | 5.26M |
| Change in Net Operating Assets | 946.00K | -7.05M | 4.45M | 26.47M | 8.65M |
| Cash from Operations | 71.30M | 60.04M | 70.88M | 72.87M | 64.14M |
| Capital Expenditure | -26.00K | -- | -88.00K | -259.00K | -10.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -26.00K | -- | -88.00K | -259.00K | -10.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.21M | 4.79M | 5.98M | 3.98M | 2.03M |
| Repurchase of Common Stock | -219.00K | -642.00K | -464.00K | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.12M | -1.09M | -1.09M | -9.95M | -874.00K |
| Cash from Financing | 872.00K | 3.06M | 4.43M | -5.97M | 1.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.14M | 63.10M | 75.22M | 66.64M | 65.28M |